Atricure, Inc.

Health Care
Medical/Dental Instruments
www.atricure.com

Earnings Score
Moat Score
Safety Score

Market Cap $1.80B
PE -40
Debt $64.67M
Cash $122.72M
EV $1.74B
FCF $745.00K

Earnings

loading chart...

Sales & Net Margins

loading chart...

Earnings	-$44.70M
EBIT	-$40.01M
ROE	-10%
ROA	-7%
FCF	$745.00K
Equity	$460.97M
Growth Stability	1
PE	-40.34
PEG	-731.78
PB	3.91
P/FCF	2.42K
P/S	3.87
Price/Cash	0.07
Debt/Equity	0.14
Debt/FCF	86.81
Net Margins	-10%
Gross Margins	75%
Op. Margins	-9%
Earnings CAGR	0%
Sales Growth YoY	17%
Sales Growth QoQ	7%
Sales CAGR	14%
Equity CAGR	17%
Earnings Stability	0
Earnings Growth YoY	59%

Earnings Growth QoQ	98%
Earnings CAGR 5Y	0%
Sales CAGR 5Y	20%
Equity CAGR 5Y	7%
Earnings CAGR 3Y	19%
Sales CAGR 3Y	19%
Equity CAGR 3Y	1%
Market Cap	$1.80B
Revenue	$465.31M
Assets	$609.33M
Total Debt	$64.67M
Cash	$122.72M
Shares Outstanding	46.97M
EV	1.74B
Earnings Score	6%
Moat Score	6%
Safety Score	73%
Final Score	28%
Working Capital	194.4M
Current Ratio	3.65
Gross Profit	$347.52M
Shares Growth 3y	1%
Equity Growth QoQ	-1%
Equity Growth YoY	-1%

Assets & ROA

loading chart...

Stockholders Equity & ROE

loading chart...

AtriCure Inc is a innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

SEC Filings

Direct access to Atricure, Inc. (ATRC) Annual Reports (10K) and Quarterly Reports (10Q) from the SEC website.

2024
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2023
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31
2022
- 10-K Dec 31
- 10-Q Sep 30
- 10-Q Jun 30
- 10-Q Mar 31

Sector Comparison

How does Atricure, Inc. compare to its competitors?

Loading chart...

Peter Lynch's Chart

This chart shows the current pricing of Atricure, Inc. compared to its past. The addition of the earnings trend line provides further insights into the company's earnings power.

CAGR 0%

Stability 0%

loading chart...

Atricure, Inc. Discounted Cash Flow

Fully customizable DCF calculator online for Atricure, Inc..

Years

Calculation mode

= $7.4M

	0	1	2	3	4	5	6	7	8	9	10	TV
fcf	$745K	$745K	$745K	$745K	$745K	$745K	$745K	$745K	$745K	$745K	$745K	$7.5M
DCF		$677K	$616K	$560K	$509K	$463K	$421K	$382K	$348K	$316K	$287K	$2.9M
Value	$7.4M

Competitiveness and MOAT

High margins render the company resilient under dire circumstances, hence able to drive competitors out or acquire them. ROE and ROA measure the average flow generated by each invested dollar. Their marginal value is a forecast of future growth, and it is considered by Buffett and Munger the most important single indicator.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Net Margins	-21%	-21%	-15%	-10%	-15%	-23%	18%	-14%	-8%	-10%	-10%
ROA	-	-11%	-9%	-5%	-6%	-6%	9%	-7%	-4%	-7%	-7%
ROE	-	-20%	-17%	-8%	-14%	-12%	10%	-10%	-7%	-10%	-10%

Bad Net Margins (-9.61%)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Safety and Stability

Being debt the number one cause of investment losses and company death, the ratio Debt/FCF is of utmost importance to guarantee safety. On the other hand the Graham’s stability measures the drawdown of earnings, hence indicating the reliability of the flow generated by the company.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	TTM
Debt over FCF	-	-1.78	-2.48	-5.51	-2.14	-2.65	-2.55	-1.68	-8.4	86.81	86.81
Debt over Equity	0	0.24	0.24	0.23	0.24	0.16	0.12	0.14	0.14	0.14	0.14
Growth Stability	-	-	-	-	-	-	-	-	-	-	1

Bad Debt/FCF ratio (86.81)

Net Margins are too low to guarantee profitability in case of higher costs or higher interest rates. Furthermore lower margins cause higher earnings’ volatility.

Good Debt/Equity ratio (0.14)

The company is not overleveraged and has a good balance between equity and debt.

Good Graham’s Stability (1)

The company has a good stability in its earnings, which is a sign of a good competitive advantage.

Growth

Growth can be dangerous when forecasting, simply projecting the current growth is in general wrong. A company passes through multiple phases, from being young and unprofitable, to the first periods of profitability and high growth, until it arrives at a period of regime with limited growth. Identifying in which phase the company is in may help forecasting.

Years	12/2015	12/2016	12/2017	12/2018	12/2019	12/2020	12/2021	12/2022	12/2023	12/2024	CAGR 5Y
Revenue YoY growth	-	20%	13%	15%	14%	-11%	33%	20%	21%	17%	20%
Earnings YoY growth	-	23%	-19%	-21%	67%	37%	-204%	-193%	-34%	47%	0%
Equity YoY growth	-	-10%	-4%	55%	-1%	67%	17%	-6%	2%	-1%	7%
FCF YoY growth	-	7%	-33%	-32%	170%	-10%	-6%	66%	-81%	-110%	-